OSCR

Transcriptomic Insights Into Alzheimer's Disease: Differentially Expressed Genes and Cholesterol Metabolism.

Overview

Authors: Rui Sun1, Xu Wang1, Zaibao Wang1,2, Chunliu Li1,2, Qing Shao1,2, Xiangru Liu1,2, Hongrui Zhu1, Sheng Wang1, Keqiang He1
  1. Department of Anesthesiology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine University of Science and Technology of China Hefei Anhui China
  2. Department of Anesthesiology Graduate School of Bengbu Medical University Bengbu Anhui China
Journal: CNS neuroscience & therapeutics, volume 32, issue 3, article e70833
Dates: received 30 November 2025; accepted 4 March 2026; published online 19 March 2026; in print March 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1002/cns.70833 · PMID 41854441 · PMCID PMC13093267 · OpenAlex W7138914790
Open access: gold, a free copy (OpenAlex)
Status: data only
Categories: genetics / omics (modality), human (organism), mouse (organism), Alzheimer's / dementia (population), cellular / molecular (subfield)
Methods: Spectral & time-frequency, Statistics, Smoothing, state filtering, decompositions, Machine learning
Keywords: Alzheimer's disease, cholesterol metabolism, machine learning, mendelian randomization
MeSH: Alzheimer Disease*, Cholesterol*, Transcriptome*, Animals, Cohort Studies, Female, Gene Expression Profiling, Humans, Machine Learning, Male, Mendelian Randomization Analysis, Mice (* major topic)
Topic: Alzheimer's disease research and treatments (Physiology, Medicine), according to OpenAlex
Funding: Hubei Chen Xiaoping Science and Technology Development Foundation (CXPJJH125001‐2537); Health Research Project of the Anhui Provincial Health Commission (AHWJ2023BAc20089); University of Science and Technology of China
Citations: cited by 1 paper (Europe PMC); 39 references in the paper

Abstract

Background: Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline and memory impairment, posing significant challenges to affected individuals, their families, and healthcare systems globally. With projections indicating that the prevalence of AD could escalate to 152 million cases by 2050, there is an urgent need to elucidate the underlying mechanisms driving this condition. Additionally, developing effective diagnostic tools to aid in its early detection and management is crucial.

Methods: In this study, we utilized a combination of Mendelian randomization and advanced machine learning techniques to analyze transcriptomic data from five distinct cohorts of Alzheimer's Disease (AD) patients. After addressing batch effects, we identified differentially expressed genes (DEGs) between the AD and control groups. Mendelian randomization analysis was conducted to assess the causal relationships between DEGs and AD risk. A Venn diagram was subsequently used to identify genes associated with cholesterol metabolism from the screened gene set. The shared DEGs were subjected to functional enrichment analyses. Furthermore, immune analysis was quantified using Gene Set Enrichment Analysis (GSEA). A diagnostic model for AD was developed by evaluating 113 combinations of 12 machine learning algorithms with 10‐fold cross‐validation on the training datasets, followed by external validation on test datasets. Finally, immunofluorescence staining was performed on mouse brain slices to verify the expression level of KLHL21.

Results: Our analyses identified a substantial number of differentially expressed genes (DEGs) demonstrating significant differences between Alzheimer's disease (AD) patients and control groups. Among these, we identified 29 genes associated with AD, with 21 of them linked to cholesterol metabolism, highlighting its pivotal role in the disease's pathogenesis. From this set, we developed a robust 8‐gene diagnostic signature (comprising CHSY1, FIBP, DHCR24, HVCN1, KIFAP3, KLHL21, LETMD1, and SLC25A29), which outperformed existing AD diagnostic models in both training and testing cohorts. Additionally, complementary animal experiments were conducted to validate the biological relevance of these genes, further elucidating their roles in AD pathology.

Conclusions: Our research identified critical genes and proposed novel pathways for early diagnosis and potential therapeutic interventions, paving the way for enhanced clinical applications in Alzheimer's disease management.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Other data links

Data Availability Statement

The data that support the findings of this study are openly available in sun00814/ad260118 at https://doi.org/10.5281/zenodo.18289856.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 30 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 9 authors, 4 keywords, 12 MeSH terms, 3 funders, 39 references.

Cite

This paper

Sun, R., Wang, X., Wang, Z., Li, C., Shao, Q., Liu, X., Zhu, H., Wang, S., & He, K. (2026). Transcriptomic Insights Into Alzheimer's Disease: Differentially Expressed Genes and Cholesterol Metabolism. CNS neuroscience & therapeutics, 32(3), e70833. https://doi.org/10.1002/cns.70833

BibTeX

@article{sun2026transcriptomic,
author = {Sun, Rui and Wang, Xu and Wang, Zaibao and Li, Chunliu and Shao, Qing and Liu, Xiangru and Zhu, Hongrui and Wang, Sheng and He, Keqiang},
title = {{Transcriptomic Insights Into Alzheimer's Disease: Differentially Expressed Genes and Cholesterol Metabolism}},
journal = {CNS neuroscience \& therapeutics},
year = {2026},
month = mar,
volume = {32},
number = {3},
pages = {e70833},
publisher = {Wiley},
issn = {1755-5930},
doi = {10.1002/cns.70833},
url = {https://doi.org/10.1002/cns.70833},
pmid = {41854441},
pmcid = {PMC13093267}
}

RIS

TY - JOUR
AU - Sun, Rui
AU - Wang, Xu
AU - Wang, Zaibao
AU - Li, Chunliu
AU - Shao, Qing
AU - Liu, Xiangru
AU - Zhu, Hongrui
AU - Wang, Sheng
AU - He, Keqiang
TI - Transcriptomic Insights Into Alzheimer's Disease: Differentially Expressed Genes and Cholesterol Metabolism
T2 - CNS neuroscience & therapeutics
J2 - CNS Neurosci Ther
PY - 2026
DA - 2026/03/01
VL - 32
IS - 3
SP - e70833
SN - 1755-5930
PB - Wiley
DO - 10.1002/cns.70833
UR - https://doi.org/10.1002/cns.70833
LA - en
ER -

CSL-JSON

{
"id": "10.1002/cns.70833",
"type": "article-journal",
"title": "Transcriptomic Insights Into Alzheimer's Disease: Differentially Expressed Genes and Cholesterol Metabolism",
"container-title": "CNS neuroscience & therapeutics",
"author": [
{
"family": "Sun",
"given": "Rui"
},
{
"family": "Wang",
"given": "Xu"
},
{
"family": "Wang",
"given": "Zaibao"
},
{
"family": "Li",
"given": "Chunliu"
},
{
"family": "Shao",
"given": "Qing"
},
{
"family": "Liu",
"given": "Xiangru"
},
{
"family": "Zhu",
"given": "Hongrui"
},
{
"family": "Wang",
"given": "Sheng"
},
{
"family": "He",
"given": "Keqiang"
}
],
"container-title-short": "CNS Neurosci Ther",
"volume": "32",
"issue": "3",
"page": "e70833",
"DOI": "10.1002/cns.70833",
"PMID": "41854441",
"PMCID": "PMC13093267",
"ISSN": "1755-5930",
"publisher": "Wiley",
"URL": "https://doi.org/10.1002/cns.70833",
"language": "en",
"issued": {
"date-parts": [
[
2026,
3,
1
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1186/s13041-026-01312-3
Sevoflurane ameliorates cerebral ischemia-reperfusion injury by modulating mitochondrial dynamics and attenuating apoptosis via Shh-YAP1 signaling pathway.
Journal: Molecular brain
In common: mouse, cellular / molecular, author Hongrui Zhu
[2] doi:10.1038/s41593-026-02267-3 [code]
Spatial proteomic analysis in human Alzheimer's disease brains enables identification of microenvironment-dependent microglial cell states.
Journal: Nature neuroscience
In common: Alzheimer's / dementia, genetics / omics, cellular / molecular, 3 references
[3] doi:10.1002/alz.71804
A meta-refined human Alzheimer's disease-associated gene subset shows partial mouse-model pathway correspondence and limited cross-cohort machine-learning transportability.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
In common: Alzheimer's / dementia, genetics / omics, mouse, 1 other category, 3 references
[4] doi:10.1038/s43587-026-01204-0
Fibronectin mediates APOE4-driven blood-brain barrier dysfunction in Alzheimer's disease.
Journal: Nature aging
In common: Alzheimer's / dementia, genetics / omics, mouse, 1 other category, 2 references
[5] doi:10.3390/brainsci16070757
Low-Intensity Focused Ultrasound Alters Alzheimer's Disease Pathology, In Vivo, as a Function of Ultrasound Dose and Age.
Journal: Brain sciences
In common: Alzheimer's / dementia, mouse, 2 references
[6] doi:10.1038/s41467-026-68864-9 [code]
Integrative epigenomic landscape of Alzheimer's Disease brains reveals oligodendrocyte molecular perturbations associated with tau.
Journal: Nature communications
In common: Alzheimer's / dementia, genetics / omics, cellular / molecular, 2 references
[7] doi:10.1093/braincomms/fcag326 [code]
Brain multiomic profiling identifies tau-related transcriptomic dysregulation in Alzheimer's disease.
Journal: Brain communications
In common: Alzheimer's / dementia, genetics / omics, cellular / molecular, 2 references
[8] doi:10.1186/s12967-026-08414-5 [code]
Integrative transcriptomic analysis identifies meningeal-hippocampal immune communication in Alzheimer's disease.
Journal: Journal of translational medicine
In common: Alzheimer's / dementia, genetics / omics, mouse, 1 other category, 2 references
[9] doi:10.1016/j.isci.2026.117038 [code]
Multi-region brain transcriptomes uncover two subtypes of aging individuals with differences in Alzheimer risk and the impact of <i>APOEε4</i>.
Journal: iScience
In common: Alzheimer's / dementia, genetics / omics, cellular / molecular, 2 references
[10] doi:10.1126/sciadv.aed6825
SORLA up-regulation suppresses pathological effects in aged tauopathy mouse brain.
Journal: Science advances
In common: Alzheimer's / dementia, genetics / omics, mouse, 1 other category, 2 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.